Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Taiwan Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20132
20144
20152
20168
20172
20187
20196
20206
20219
20224
20234
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting19
Terminated9
Recruiting7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
AbbVie9
Novartis Pharmaceuticals9
Daiichi Sankyo4
Eli Lilly and Company4
Amgen2
Arcus Biosciences, Inc.2
Blueprint Medicines Corporation2
Boehringer Ingelheim2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung63
Neoplasms22
Colorectal Neoplasms11
Lung Neoplasms10
Ovarian Neoplasms10
Triple Negative Breast Neoplasms10
Squamous Cell Carcinoma of Head and Neck9
Stomach Neoplasms9
Neoplasm Metastasis8
Melanoma7

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.